Business
Corner Therapeutics to hyperactivate 'the brains of the immune system' with $54M launch - Endpoints News
Corner Therapeutics' $54 million Series A will be used to bring new immunotherapies for cancer and infectious diseases into the clinic, the company said Thursday. The startup is led by Steve Altschuler, who co-founded Spark Therapeutics and was previ
By: Endpoints News
- Apr 19 2024
- 0
- 0 Views
CorÂner TherÂaÂpeuÂtics’ $54 milÂlion SeÂries A will be used to bring new imÂmunotherÂaÂpies for canÂcer and inÂfecÂtious disÂeases inÂto the clinÂic, the comÂpaÂny said ThursÂday.
The startÂup is l… [+580 chars]